Versalya
FDA import alert and refusal historyAlcobendas, SpainFEI 3017724688
Recorded by FDA as VERSALYA
As of October 26, 2026, Versalya is not on any FDA import alert in SupplierRadar's records; FDA refused 1 of its shipment line on April 11, 2025, most often for unapproved new drug (UNAPPROVED).
Data from FDA public records, last checked . Request a correction
Current status
- Import alerts
- Not listed
- Last import refusal
- Folic acid (vitamin) · UNAPPROVED
- Last warning letter
- None found
- Last inspection
- None on record
Every FDA record for Versalya
1 record, newest first. Each line links to the FDA page it came from.
2025
- Import refusalRefused, Folic acid (vitamin)UNAPPROVEDEntry AEK-8422302-1Source
Refusal charges, in plain English
- UNAPPROVED1 refused line
Unapproved new drug
The product appeared to be a new drug within the meaning of section 201(p) of the FD&C Act without an approved New Drug Application. FDA can apply this charge to a food or supplement whose labeling presents it for drug uses.
Questions about Versalya
- Is Versalya on an FDA import alert?
- No listing for Versalya appears in the FDA import alerts SupplierRadar checked on October 26, 2026. Country-wide alerts may still apply to its products; see the Spain page.
- Has FDA refused shipments from Versalya?
- Yes. FDA refused 1 shipment line from Versalya on April 11, 2025. The most recent, on April 11, 2025, was folic acid (vitamin), charged as UNAPPROVED (unapproved new drug).
- Why did FDA refuse Versalya's shipments?
- The most frequent charge is UNAPPROVED (unapproved new drug, 1 line).
- What is Versalya's FEI number?
- Versalya's FDA Establishment Identifier (FEI) is 3017724688.
Buying from Versalya?
Watch it and get the FDA record the day it changes. Free for one supplier.
SupplierRadar is not affiliated with the U.S. Food and Drug Administration. Data comes from public FDA records and may contain errors. This is not legal advice; importers remain responsible for their supplier evaluations.